Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair

Biotechnology and Bioengineering

Volumn 109, Issue 1, 2012, Pages 274-283

  Simpson, David L ^a   Boyd, Nolan L ^b   Kaushal, Sunjay ^c   Stice, Steve L ^d   Dudley, Samuel C ^a  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cell transplantation E04.936.225 ; Embryonic stem cells A11.872.190 ; Mesenchymal stem cells A11.872.580 ; Myocardial infarction C14.280.647.500 ; Tissue engineering E05.200.249.750

Indexed keywords

ATHYMIC; BONE MARROW; CARDIAC REPAIR; CELL DELIVERY; CELL THERAPY; CELL TRANSPLANTATION; CELL TYPES; EMBRYONIC STEM CELLS; EMBRYONIC STEMS; END-DIASTOLIC; EX VIVO EXPANSION; FRACTIONAL AREA; HUMAN EMBRYONIC STEM CELLS; HUMAN MESENCHYMAL STEM CELLS; IN-VITRO; MESENCHYMAL CELLS; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; NON-VIABLE; WALL THICKNESS;

CELL GROWTH; COLLAGEN; ENDOTHELIAL CELLS; REPAIR; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL CULTURE;

COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART SURGERY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT;

ANIMALS; BLOOD PRESSURE; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; RATS; TISSUE ENGINEERING; TREATMENT OUTCOME;

RATTUS;

EID: 81455131612     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23301     Document Type: Article

References (30)

1. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102(32): 11474-11479.
2. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. 2006. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355(12): 1222-1232.
3. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, Morine KJ, Gardner TJ, Discher DE, Sweeney HL. 2006. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290(6): H2196-H2203.
4. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. 2009. Human Embryonic Stem Cell-Derived Mesoderm-like Epithelium Transitions to Mesenchymal Progenitor Cells. Tissue Eng Part A 15: 1897-1907.
5. Breland UM, Halvorsen B, Hol J, Oie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Froland SS, Haraldsen G, Gullestad L, Damas JK, Hansson GK, Aukrust P. 2008. A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 28(5): 1005-1011.
6. Chen L, Tredget EE, Wu PY, Wu Y. 2008. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3(4): e1886.
7. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. 2005. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112(2): 214-223.
8. Diederichsen AC, Moller JE, Thayssen P, Junker AB, Videbaek L, Saekmose SG, Barington T, Kristiansen M, Kassem M. 2008. Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study-congestive heart failure trial (DanCell-CHF). Eur J Heart Fail 10(7): 661-667.
9. Grinnemo KH, Mansson-Broberg A, Leblanc K, Corbascio M, Wardell E, Siddiqui AJ, Hao X, Sylven C, Dellgren G. 2006. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 38(2): 144-153.
10. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K. 2001. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65(9): 845-847.
11. Hou M, Yang KM, Zhang H, Zhu WQ, Duan FJ, Wang H, Song YH, Wei YJ, Hu SS. 2007. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 115(2): 220-228.
12. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ. 2007. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25(9): 2363-2370.
13. Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Dong A, Du Y, Huang X, Wang J, Lei X, Zheng X. 2006. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch.
14. Li JH, Zhang N, Wang JA. 2008. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Invest 31(2): 103-110.
15. Liu D, Yi C, Zhang D, Zhang J, Yang M. 2010. Inhibition of proliferation and differentiation of mesenchymal stem cells by carboxylated carbon nanotubes. ACS Nano 4(4): 2185-2195.
16. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K. 2006. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355(12): 1199-1209.
17. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. 2005. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112(8): 1128-1135.
18. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R, Benetti F. 2005. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130(6): 1631-1638.
19. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107(18): 2294-2302.
20. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, Doronin SV. 2007. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25(7): 1761-1768.
21. Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM, Cassatella MA. 2004. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol 172(8): 5034-5040.
22. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. 2004. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44(8): 1690-1699.
23. Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr. 2007. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25(9): 2350-2357.
24. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML. 2007. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 102(6): 2104-2111.
25. Tang YL. 2005. Autologous mesenchymal stem cells for post-ischemic myocardial repair. Methods Mol Med 112: 183-192.
26. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI. 2005. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80(1): 229-236; discussion 236-237.
27. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI. 2004. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117(1): 3-10.
28. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. 2003. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361(9351): 47-49.
29. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429): 141-148.
30. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. 2007. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21(12): 3197-3207.